The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy

Published:2017-08-23 Issue:11 Volume:12 Page:1169-1178
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Russo Emilio¹,Citraro Rita¹,Mula Marco²³

Affiliation:

1. Science of Health Department, School of Medicine and Surgery, University of Catanzaro, Catanzaro, Italy

2. Atkinson Morley Regional Neuroscience Centre, St George’s University Hospitals NHS Foundation Trust, London, UK

3. Institute of Medical and Biomedical Education, St George’s University of London, London, UK

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1366985

Reference81 articles.

1. Incidence of epilepsy: A systematic review and meta-analysis

2. The global burden and stigma of epilepsy

3. Patterns of treatment response in newly diagnosed epilepsy

4. Brivaracetam for the treatment of epilepsy in adults

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond;Neurological Sciences;2024-04-01

2. Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis;Frontiers in Neurology;2023-07-06

3. Synthesis and biological evaluation of new antiseizure compounds derived from valproic acid;Future Medicinal Chemistry;2023-05

4. A review of cognitive and behavioral outcomes of Brivaracetam;The Kaohsiung Journal of Medical Sciences;2023-01-20

5. BRIVEST: A ‘real-world’ observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam;Epilepsy & Behavior;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3